Neuronal IL-1R1 Signaling in Mild Closed Head Injury
轻度闭合性头部损伤中的神经元 IL-1R1 信号转导
基本信息
- 批准号:10656547
- 负责人:
- 金额:$ 42.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAgeAnimal Disease ModelsAnti-Inflammatory AgentsAttentionAutoimmune DiseasesAxonBehaviorBehavioral AssayBrainCellsChronicClosed head injuriesComplexDataDevelopmentElectrophysiology (science)ExhibitsFDA approvedFormulationFunctional disorderGene Expression ProfileGenesGoalsInflammationInflammatoryInflammatory ResponseInjuryInterleukin SuppressionInterleukin-1Interleukin-1 ReceptorsInterventionKnockout MiceKnowledgeLoxP-flanked alleleMaintenanceMediatingMemoryModelingMusNatureNerve DegenerationNervous System TraumaNeurodegenerative DisordersNeurogliaNeuronsPathway interactionsPeripheralPhasePhenotypePhysiologyProcessReceptor SignalingRecoveryRiboTagRoleSignal TransductionSynapsesSynaptic plasticitySystemTestingTherapeuticTissuesTraumatic Brain Injurycell typecognitive functioncognitive recoverycytokineexperimental studygenetic approachinducible Creinflammatory milieuinterleukin-1 receptor accessory proteinknock-downmouse modelnerve injurynervous system disorderneuroinflammationneuroprotectionneuroregulationnovelpreservationresponsesynaptic function
项目摘要
ABSTRACT
The cytokine interleukin-1 (IL-1) is well known to mediate detrimental inflammatory processes in peripheral
tissues. IL-1 is elevated in age and in neurodegenerative disease. As a result, IL-1 has become a major focus
of anti-inflammatory strategies to treat neuroinflammation following acute injury and in chronic
neurodegenerative disease. Surprisingly, there is scant evidence that neurons are damaged through the direct
actions of IL-1. To the contrary, a neuron-specific “non-canonical” IL-1 receptor (IL-1R1) pathway that
promotes, rather than erodes, neuronal viability has been identified. Despite this paradigm-shifting observation,
the non-canonical pathway has received little attention. Much remains unknown about how neuronal IL-1R1
signaling contributes to the brain's inflammatory milieu, synaptic physiology, and cognitive function, and
recover from injury and progression of neurodegeneration. This knowledge gap could undermine potential
neuroprotective approaches that target suppression of IL-1 as part of the mechanism-of-action.
To address this knowledge gap, we will use novel mouse models exhibiting neuron-specific modulation of IL-1
signaling (i.e., IL-1R1-floxed mice to look at neuron-specific knockdown and IL-1R1-restore mice to look at the
neuron-specific expression of IL-1R1). Our overarching hypothesis is that neuronal IL-1R1 signaling is
inherently protective.
We will test this hypothesis in the following Specific Aims:
SA1 Define the role of the neuronal IL-1R1 pathway in the inflammatory response to a CHI in mice.
SA2 Define the neuronal IL-1R1 pathway in homeostatic synaptic plasticity after a CHI in mice.
SA3 Determine the temporal role of neuronal IL-1R1 in the cognitive recovery following a CHI.
If our hypothesis is affirmed, we will provide knowledge of a new neuroprotective approach and enable the
development of new formulations of existing anti-inflammatory interventions that preserve the neuroprotective
functions of IL-1. The development of novel IL-1R1 therapies would include agents that only suppress the
inflammatory IL-1R1 pathway or only activate the neuroprotective IL-1R1 pathway.
抽象的
众所周知,细胞因子白介素1(IL-1)介导周围有害炎症过程
IL-1年龄和神经退行性疾病的升高。结果,IL-1已成为主要重点
急性损伤和慢性病后治疗神经炎症的抗炎策略
神经退行性疾病。令人惊讶的是,有很少的证据表明神经元通过直接受损
IL-1的动作。相反,神经特异性的“非典型” IL-1受体(IL-1R1)途径
已经确定了促进而不是侵蚀,而不是侵蚀。尽管有这种范式移动观察,但
非经典途径很少受到关注。关于神经元IL-1R1的未知
信号传导有助于大脑的炎症环境,突触生理和认知功能,以及
从损伤和神经退行性的进展中恢复。这种知识差距可能破坏潜力
神经保护方法将靶向IL-1作为行动机理的一部分。
为了解决这个知识差距,我们将使用具有IL-1神经特异性调制的新型鼠标模型
信号传导(即IL-1R1-氯曲线小鼠,以查看神经特异性敲低和IL-1R1-restore小鼠,以查看
IL-1R1的神经元特异性表达)。我们的总体假设是神经元IL-1R1信号是
固有的保护。
我们将在以下具体目的中检验这一假设:
SA1定义了神经元IL-1R1途径在小鼠炎症反应中的作用。
SA2定义小鼠CHI后稳态突触可塑性中的神经元IL-1R1途径。
SA3确定神经元IL-1R1在CHI后认知恢复中的临时作用。
如果我们的假设得到肯定,我们将提供一种新的神经保护方法的知识,并使
开发保留神经保护性的现有抗炎干预措施的新公式
IL-1的功能。新型IL-1R1疗法的发展将包括只能抑制的药物
炎性IL-1R1途径或仅激活神经保护性IL-1R1途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ADAM D BACHSTETTER其他文献
ADAM D BACHSTETTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ADAM D BACHSTETTER', 18)}}的其他基金
Drug repurposing for Alzheimer’s disease-related inflammation caused by a TBI
药物再利用,治疗 TBI 引起的阿尔茨海默病相关炎症
- 批准号:
10590132 - 财政年份:2023
- 资助金额:
$ 42.91万 - 项目类别:
Neuronal IL-1R1 Signaling in Mild Closed Head Injury
轻度闭合性头部损伤中的神经元 IL-1R1 信号转导
- 批准号:
10518172 - 财政年份:2022
- 资助金额:
$ 42.91万 - 项目类别:
Translational Approaches to Mitigate Enhanced Alzheimer’s Disease Risk Following a Mild TBI
减轻轻度 TBI 后阿尔茨海默病风险增加的转化方法
- 批准号:
10090757 - 财政年份:2021
- 资助金额:
$ 42.91万 - 项目类别:
Administrative Supplement to Sleep Fragmentation and Alzheimer's Disease
睡眠碎片化和阿尔茨海默病的行政补充
- 批准号:
10555721 - 财政年份:2020
- 资助金额:
$ 42.91万 - 项目类别:
Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain Injury
脑外伤后 IL-1/IL-1R1 信号传导的细胞特异性作用
- 批准号:
10307112 - 财政年份:2018
- 资助金额:
$ 42.91万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
- 批准号:
10748859 - 财政年份:2024
- 资助金额:
$ 42.91万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 42.91万 - 项目类别:
Sex-specific Impact of Prenatal Opioids on Brain Reward Signaling and Neonatal Feeding Regulation
产前阿片类药物对大脑奖赏信号和新生儿喂养调节的性别特异性影响
- 批准号:
10506345 - 财政年份:2023
- 资助金额:
$ 42.91万 - 项目类别:
Traumatic Brain Injury Anti-Seizure Prophylaxis in the Medicare Program
医疗保险计划中的创伤性脑损伤抗癫痫预防
- 批准号:
10715238 - 财政年份:2023
- 资助金额:
$ 42.91万 - 项目类别: